Induction FOLFOX with chemoradiation and chemotherapy in G/GEJ cancer 

Gahyun Gim, MD, University of Rochester Medical Center, Rochester, NY, discusses the Phase II trial (NCT03110926) of induction FOLFOX followed by chemoradiation with carboplatin and paclitaxel in treating stage II-III esophageal and gastroesophageal junction (G/GEJ) cancers. The regimen demonstrated a favorable safety profile with promising survival outcomes. This interview took place at 2024 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Annual Congress in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.